The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...

The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...

MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...

The Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

FRIDAY, Dec. 27, 2024 (HealthDay News) -- People with multiple sclerosis (MS) have been concerned that a COVID-19 infection could cause the symptoms of their nerve disease to become even worse.

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.